Entrada Therapeutics (TRDA) PT Raised to $28 at Oppenheimer
Tweet Send to a Friend
(Updated - November 6, 2024 7:44 AM EST)
Oppenheimer analyst Hartaj Singh raised the price target on Entrada Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Hartaj Singh raised the price target on Entrada Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
